Home > Healthcare > Pharmaceuticals > Finished Drug Form > Regenerative Medicine Market

Regenerative Medicine Market Size

Report ID: GMI4571
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Regenerative Medicine Market Size

Regenerative Medicine Market size is valued to be USD 52.3 billion in 2022 and is projected to grow at CAGR of 20.4% and reach USD 328.9 billion by 2032. Regenerative medicine is field of medicinal science that aims towards development of products to replace, regrow or repair damaged tissues, cells and organs. It provides advanced therapies for range of diseases with the help of stem cells and tissue engineering.

To get key market trends

Download Free Sample

Further, several ongoing clinical studies to understand the potential of regenerative medicine in new therapeutic applications will result into numerous product launches in coming years. With increasing product development activities and expanding clinical applications, the market will witness lucrative growth in future.

Regenerative Medicine Market Report Attributes
Report Attribute	Details
Base Year:	2022
Regenerative Medicine Market Size in 2022:	USD 52.3 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	20.4%
2032 Value Projection:	USD 328.9 Billion
Historical Data for:	2018 to 2022
No. of Pages:	100
Tables, Charts & Figures:	176
Segments covered:	Type, Application, and Region
Growth Drivers:	Growing prevalence of chronic diseases worldwide Rising investment in development of innovative medicines High adoption of stem cell technology in disease treatment Strong product pipeline of potential therapies
Pitfalls & Challenges:	Stringent regulatory framework High cost associated with some regenerative medicine therapy

Learn more about the key segments shaping this market

Download Free Sample

Regenerative medicine has offered several benefits over conventional treatment method including faster recovery. For instance, stem cells and platelet-rich plasma allows faster repairing of injured joints and tissue that enhances the body's own ability to heal. Further, it also helps to reduce inflammation and prevent scar tissue formation. Additionally, some promising approaches including stimulation of endogenous stem cells for in situ repair and organoids transplantation to repair minor tissue injury will continue to drive the industry growth potential in coming years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global regenerative medicine industry was worth USD 52.3 billion in 2022 and is projected to grow at CAGR of 20.4% through 2032, driven by the increasing product development activities and expanding clinical applications.

Musculoskeletal segment accounted for a major market share of 31.6% in 2022, backed by the increasing prevalence of musculoskeletal diseases such as osteoarthritis, rheumatoid arthritis, and several orthopedic disorders.

North America regenerative medicines market accounted for a revenue share of 45.5% in 2022 and will continue growth over 2023-2032, favored by the increasing adoption of innovative treatment therapies along with growing prevalence of chronic diseases.

Novartis AG, Amgen, Inc., Bristol Myers Squibb, BLUEBIRD BIO, GC Pharma, GlaxoSmithKline plc, ANTEROGEN, BIOSOLUTIONS, TERUMO BCT, AVITA MEDICAL, Smith and Nephew, and ORGANOGENESIS.